Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001287575 | SCV001474277 | likely benign | Telangiectasia, hereditary hemorrhagic, type 1 | 2020-05-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001459020 | SCV001662853 | likely benign | Hereditary hemorrhagic telangiectasia | 2022-07-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003294187 | SCV004005050 | likely benign | Cardiovascular phenotype | 2023-05-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |